European Pharmaceutical Review
APRIL 10, 2025
In the EU, a joint PFAS Restriction Proposal under REACH was submitted, aiming for a full ban by 2028/2030. This poses a significant challenge for pharmaceutical manufacturers, not least because of the technical challenges related to operations, supply chain and the environment. There is worldwide concern around the use of PFAS.
European Pharmaceutical Review
JULY 18, 2023
A market report by Meticulous Research has reported that rising pressure to reduce overall process costs has meant many pharma and biotech manufacturers are focusing on streamlining their processes by using quality management systems. According to the research, the pharmaceutical quality management systems market is projected to reach $3.97
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
JUNE 10, 2024
The first industrial-scale pharmaceutical manufacturing facility for production of lead-212-based radioligand therapies has been inaugurated. The company hopes to produce this number tenfold by the end of 2030.
European Pharmaceutical Review
OCTOBER 31, 2022
According to the Intergovernmental Panel on Climate Change (IPCC), emissions must achieve reduction of 43 percent by 2030. Sustainable energy strategies for pharmaceutical manufacturers… The post Biopharma successful in achieving climate-related goals, report finds appeared first on European Pharmaceutical Review.
European Pharmaceutical Review
DECEMBER 21, 2022
2 However, most of these efforts relating to catalysis, 3 process waste metrics, 4 lifecycle assessments, 5 pharmaceuticals in the environment 6 and the phase out of substances of concern 7 mainly mitigate the consequences of pharmaceutical manufacturing. So, when could the goal of a net zero pharmaceutical industry be achieved?
PM360
AUGUST 9, 2022
billion in 2030 at a CAGR of 9.2%. Launched in July 2021, Prescryptive Health provides next-generation, mobile market access and medication adherence solutions for pharmaceutical manufacturers. Pharmaceutical manufacturers can customize the solution based on the brand’s objectives and patient population’s needs.
Medico Reach
FEBRUARY 8, 2023
The global pharmaceutical manufacturing market stood at USD 405.52 The paradigm shift towards integrated, intelligent, and data-rich technologies is propelling the growth of medicines manufacturing. from 2022 to 2030, the pharma industry will reach USD 9,241.34 million by 2030. from 2023 to 2030.
Expert insights. Personalized for you.
52 
Let's personalize your content